Gapping up
In reaction to earnings/guidance:
- FIVE +8%, GWRE +4.7%, CONN +4.7%, HOFT +3.8%, MIK +3.7%, SPWH +3.5%, SIG +3.2%, CPRT +2.5%, MDB +2.3%, MEI +2.1%, GCO +2%, DCI +0.9%, POR +0.8%, PVH +0.8%, PDCO +0.7%
Other news:
- STRO +15.3% (to discuss update on "promising" STRO-002 interim data)
- FLGT +12.7% (partners with NYC for back-to-school COVID-19 testing)
- ADMA +12.7% (launches COVID-19 ImmunoRank Neutralization MICRO-ELISA)
- AGTC +8% (to provide update on trial and data on Sep 9)
- NVAX +5.6% (announces publication of Phase 1 data for COVID-19 vaccine in NEJM)
- ICLK +4.9% (upsizes and prices stock offering)
- BE +4.3% (co and SK E&C announce 28-MW deployment of fuel cell technologies)
- BKR +3% (President/CEO disclosed the purchase of ~71K shares on 9/2)
- CRY +1.5% (acquires Ascyrus Medical)
- SONO +1.2% (gets extension on exclusion of the co's core speaker products from tariffs through end of 2020)
- COST +1% (reports Q4 sales slightly better than consensus; Aug comps +14.5%)
Analyst comments:
- CS +2.5% (upgraded to Outperform from Neutral at Exane BNP Paribas)
- LLY +1.6% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- AGCO +1.5% (upgraded to Buy from Neutral at BofA Securities)
- BAC +1.1% (upgraded to Buy from Hold at Deutsche Bank)
- JPM +1% (upgraded to Buy from Hold at Deutsche Bank)
- BYND +1% (initiated with an Outperform at Robert W. Baird)